FDA recently notified its field personnel who are responsible for imports that it may detain certain products containing kratom (Mitragyna speciosa), an herb that comes from a tree in Southeast Asia, without physical inspection because the agency determined the substance is a botanical that qualifies as a new dietary ingredient (NDI) and poses adverse health effects ranging from aggression to nervousness, hallucinations and sleeplessness.